Nalaganje...

Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

Purpose: Vandetanib is a once-daily oral inhibitor of vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinases that also inhibits rearranged during transfection kinase activity. Vandetanib (300 mg/d) has previously demonstrated antitumor activity in patient...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Robinson, Bruce G., Paz-Ares, Luis, Krebs, Annetta, Vasselli, James, Haddad, Robert
Format: Artigo
Jezik:Inglês
Izdano: The Endocrine Society 2010
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2902067/
https://ncbi.nlm.nih.gov/pubmed/20371662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2009-2461
Oznake: Označite
Brez oznak, prvi označite!